AbbVie (ABBV) stock

Last close 293.89 USD (Nov 10, 2026), on the day +0.2 %.

• Sector: Healthcare, Drug Manufacturers - General.
• Market cap: 518.4B USD.
• P/E: 50.4. Forward P/E: 18.1.
• Dividend yield: 2.38 %.
• Over 52 weeks: low 197.38 USD, high 294.89 USD, price change +34.4 %.
• Analysts' average 12-month target from Yahoo Finance: 311 USD (26 analysts). Not our estimate.

Earnings

• Feb 3, 2027: EPS not yet, estimate 3.88
• Oct 30, 2026: EPS 3.82, estimate 3.76
• Jul 31, 2026: EPS 3.65, estimate 3.61
• Apr 29, 2026: EPS 2.65, estimate 2.67
• Feb 4, 2026: EPS 2.71, estimate 2.65
• Oct 31, 2025: EPS 1.86, estimate 1.78

Which large investors hold it

• Larry Robbins – 0.7 % of the portfolio
• Tom Russo – 0.0 % of the portfolio
• Ray Dalio – 0.0 % of the portfolio
• Dodge & Cox – 0.0 % of the portfolio

In baskets

• Pharma

Similar companies: AMGN · AZN · BIIB · BMY · GILD · GSK · JNJ · LLY · MRK · NOVN.SW · NVO · PFE